Pharmaceuticals: Major
Major Norwegian companies producing pharmaceuticals
Global pharmaceutical corporations develop and distribute prescription medications at a massive scale. Patent expirations, pipeline approvals, and healthcare legislation serve as major catalysts for trading activity and industry liquidity. Market data indicates that Nykode Therapeutics ASA is currently the highest-volume asset, while Vistin Pharma ASA tops the 24-hour return list. The table below tracks the vital technical and fundamental metrics for these equities.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 NYKDNykode Therapeutics ASA | 1.2 B NOK | 2.990 NOK | +1.01% | 684.65 K | 0.85 | — | −0.69 NOK | −21.37% | 32.52% | Health technology | Strong buy |
 VISTNVistin Pharma ASA | 835.9 M NOK | 18.85 NOK | +1.89% | 6.29 K | 0.58 | 13.35 | 1.41 NOK | −19.82% | 5.31% | Health technology | No rating |
 LYTIXLytix Biopharma ASA | 615.2 M NOK | 7.90 NOK | −1.25% | 11.9 K | 0.46 | — | — | — | 0.00% | Health technology | No rating |
 ONCINOncoinvent ASA | 409.38 M NOK | 62.6 NOK | −0.32% | 17.97 K | 1.09 | — | −83.40 NOK | +68.23% | 0.00% | Health technology | Strong buy |
 ABSArctic Bioscience AS | 72.78 M NOK | 2.39 NOK | −11.48% | 17.89 K | 5.62 | — | −1.49 NOK | +11.06% | 0.00% | Health technology | No rating |